CRP Apheresis in STEMI

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 202 participants.

Also called NCT04939805

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 202 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04939805
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04939805. Randomized; single masking; primary purpose treatment. Start 2021-04-01 (actual); primary completion 2026-01-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CRP Apheresis in STEMI
Condition
ST Elevation Myocardial Infarction
Condition
C-Reactive Protein
Condition
Apheresis
Condition
Myocardial Injury
Intervention (Device)
Selective CRP apheresis using the PentraSorb®-CRP system
Lead sponsor
Medical University Innsbruck (class: other)

Record details

Record id
cardio:ct-nct04939805
Content hash
d2687b031a0daa5e3fc4bc353f803903c0ce24566c2cb441bfaa84861d09902c